Pharmacological Studies on 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a Novel Antiinflammatory Agent. 4th Communication: Inhibitory Effect on the Production of Interleukin-1 and Interleukin-6.-Reference-Cited by-同舟云学术

Pharmacological Studies on 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a Novel Antiinflammatory Agent. 4th Communication: Inhibitory Effect on the Production of Interleukin-1 and Interleukin-6.

Published:1992 Issue:11 Volume:15 Page:649-655
ISSN:0386-846X
Container-title:Journal of Pharmacobio-Dynamics
language:en
Short-container-title:Journal of Pharmacobio-Dynamics

Author:

TANAKA Keiichi,AIKAWA Yukihiko,KAWASAKI Hiroki,ASAOKA Keiko,INABA Takihiro,YOSHIDA Chosaku

Publisher

Pharmaceutical Society of Japan

Subject

Pharmacology

Link

http://www.jstage.jst.go.jp/article/bpb1978/15/11/15_11_649/_pdf

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review;Neuro-Oncology Advances;2024-01-01

2. Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases;Frontiers in Immunology;2023-09-21

3. Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression;Arthritis Research & Therapy;2023-08-18

4. Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study;Modern Rheumatology;2022-08-13

5. Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs;Journal of Orthopaedic Surgery and Research;2021-07-16